Michael J. Reardon


Michael J. Reardon, MD, FACC

Houston Methodist DeBakey Heart and Vascular Center

Professor of Cardiothoracic Surgery/Allison Family Distinguished Chair of Cardiovascular Research/Surgical Director of Structural Heart Disease

Dr. Michael Reardon grew up in Houston, Texas, where he attended Baylor College of Medicine graduating with honors and as a member of AOA. He completed a 5-year general surgery residency under Dr. Michael DeBakey in the Baylor Affiliated Hospitals and a 2 year cardiothoracic residency under Dr. Denton Cooley at the Texas Heart Institute. He started and ran his own private practice as well as serving full time on the faculty of Baylor College of Medicine where he was Professor of Surgery with tenure, Chief of Cardiothoracic Surgery, Program Director for the Thoracic Surgery Residency and Vice Chair of Academic Affairs in the Department of Surgery. He has spent his entire career at The Methodist Hospital serving in numerous administrative positions including President of the Medical Staff. Currently, Dr. Reardon is Professor of Cardiothoracic Surgery, Allison Family Distinguished Chair of Cardiovascular Research, Senior Attending Surgeon at The Methodist Hospital, Senior Scientist the Houston Methodist Research Institute and Surgical Director of Structural Heart Disease at the Houston Methodist Hospital. He also serves as Clinical Professor of Cardiothoracic Surgery at the M.D. Anderson Cancer Center. He has written over 800 medical and scientific papers, book chapters and abstracts and frequently lectures on his research and clinical interests of cardiac valvular disease, thoracic aortic disease and cardiac tumors. In 1998, Dr. Reardon performed the first successful autotransplant worldwide for a malignant left atrial sarcoma and the first successful autotransplant for a malignant left ventricular sarcoma in 2003. Since then, Dr. Reardon has performed more than 52 such surgeries has traveled to Poland, Belgium, New Zealand and Israel to perform these surgeries. He presently serves as the national surgical Principal Investigator for the SURTAVI, Evolut Low Risk Randomized, Reprise III and Accurate TAVR trials.

Houston, United States

My Schedule

No Schedule currently available.